Uniqure NV
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Show More...
-
Website https://www.uniqure.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 14.47 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -1.27 -1.11 -2.1 -2.91 -3.72 -2.93 -2.94 -2.34 -3.11 -3.0 Dividends USD Payout Ratio % * Shares Mil 18.0 18.0 18.0 17.0 22.0 25.0 27.0 36.0 40.0 42.0 Book Value Per Share * USD 3.59 6.03 3.22 0.63 5.35 8.01 6.66 Free Cash Flow Per Share * USD -2.9 0.59 -3.46 -2.77 -2.37 -2.5 Return on Assets % -118.9 -261.5 -121.08 -52.9 -41.01 -32.26 -39.64 -34.46 -34.38 -36.42 Financial Leverage (Average) 7.0 2.22 2.03 2.99 2.35 1.52 1.39 1.4 Return on Equity % -302.9 -149.95 -85.4 -75.54 -103.61 -61.94 -49.42 -55.03 Return on Invested Capital % -287.02 -374.92 -89.88 -65.64 -60.93 -79.53 -51.66 -40.17 -42.38 Interest Coverage -43.02 -176.3 -28.93 -9.71 -16.88 -32.25 -34.6 -37.46 -31.6 -31.5 Current Ratio 0.59 0.2 2.65 4.68 8.59 6.34 8.47 11.85 12.15 12.89 Quick Ratio 0.59 0.2 2.53 4.62 8.55 6.24 8.37 11.77 11.97 12.62 Debt/Equity 1.19 0.38 0.11 0.31 0.22 0.2 0.2 0.23